Back to today’s briefing

Story perspectives

FDA Approves Innovative Device for PTSD Treatment

9/23/2025

31 6

Summary

Story summary

The Food and Drug Administration (FDA) approved a neuromodulation device for posttraumatic stress disorder (PTSD) treatment.
It marks the first clearance of this kind for PTSD therapies.
Animated characters are integrated into the treatment approach.
Israel is described as at the forefront of this development.
The device could significantly alter therapy sessions and reflect growing recognition of PTSD.

1 of 1

Story summary

The Food and Drug Administration (FDA) approved a neuromodulation device for posttraumatic stress disorder (PTSD) treatment.
It marks the first clearance of this kind for PTSD therapies.
Animated characters are integrated into the treatment approach.
Israel is described as at the forefront of this development.
The device could significantly alter therapy sessions and reflect growing recognition of PTSD.